Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Testicular Neoplasms 5Prostatic Neoplasms 5Urinary Bladder Neoplasms 4Testicular Germ Cell Tumor 4Seminoma 3Ovarian Neoplasms 3Endodermal Sinus Tumor 3Central Nervous System Neoplasms 3Urethral Neoplasms 2Teratoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Embryonal 2Wilms Tumor 1Ureteral Neoplasms 1Stomach Neoplasms 1Renal Pelvis and Ureter Urothelial Carcinoma 1Pancreatic Neoplasms 1Pain 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Melanoma 1Kidney Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Dysgerminoma 1Carcinoma, Transitional Cell 1Breast Neoplasms 1

Interventions

Paclitaxel 2pegfilgrastim 1Taxes 1Sunitinib 1Lapatinib 1Imatinib Mesylate 1Ifosfamide 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × pegfilgrastim × Genitourinary × Clear all
NCT00470366 2017-11-28

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
60 enrolled 11 charts
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Dysgerminoma, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡